InvestorsHub Logo
Followers 122
Posts 17458
Boards Moderated 0
Alias Born 01/06/2014

Re: None

Wednesday, 04/22/2020 10:27:57 AM

Wednesday, April 22, 2020 10:27:57 AM

Post# of 426304
Although Fish & Richardson have a pretty impressive resume (including a $2.5 billion win), winning Amarin's case may eclipse all their combined wins - this could literally be a $30+ BILLION difference (USA market vs no USA market).

Imagine being able to say that we are single handedly responsible for bringing (back) this multibillion dollar drug to the US market?

Imagine looking back to this AC ruling in 10 years, when Vascepa's cumulative USA sales are in tens of billions and/or it's the #1 sold drug of all time - how much 'street cred' Fish & Richardson will gain from this?

I hope that they are all in.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News